Mobidiag
About:
Mobidiag is a Molecular diagnostic company developing and commercializing solutions for the detection of infectious diseases.
Website: http://www.mobidiag.com/
Twitter/X: mobidiag
Top Investors: European Investment Bank, Business Finland, Springvest, Autobio Diagnostics
Description:
Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.
$74.1M
$1M to $10M
Espoo, Southern Finland, Finland
2000-01-01
sales(AT)mobidiag.com
Mart Saarma
51-100
2020-01-07
Private
© 2025 bioDAO.ai